Nuclear Factor-κB (NF-κB) Is a Novel Positive Transcriptional Regulator of the Oncogenic Wip1 Phosphatase
Open Access
- 19 February 2010
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 285 (8), 5249-5257
- https://doi.org/10.1074/jbc.m109.034579
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Loss of Wip1 Sensitizes Cells to Stress- and DNA Damage-induced ApoptosisPublished by Elsevier BV ,2009
- Is NF-κB a good target for cancer therapy? Hopes and pitfallsNature Reviews Drug Discovery, 2009
- NF-κB and cancer—identifying targets and mechanismsCurrent Opinion in Genetics & Development, 2008
- The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathwaysCancer and Metastasis Reviews, 2008
- Shared Principles in NF-κB SignalingCell, 2008
- NF-κB-mediated adaptive resistance to ionizing radiationFree Radical Biology & Medicine, 2007
- Integrating cell-signalling pathways with NF-κB and IKK functionNature Reviews Molecular Cell Biology, 2007
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasiaNature, 2003
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999